Intelligence · Clinical Pipeline
Kailera Therapeutics Pipeline
All ClinicalTrials.gov programs at Kailera Therapeutics — phase, modality, and trial IDs.
- Programs
- 5
Quick answer
Kailera Therapeutics has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Identical to kai-9531 solution for injection without active drug, KAI-9531, KAI-9531, KAI-9531
Kailera Therapeutics
Obesity
1 trial -
KAI-9531
Kailera Therapeutics
Obesity
3 trials -
KAI-9531
Kailera Therapeutics
Obesity With Diabetes
1 trial -
KAI-9531, KAI-9531, Identical to kai-9531 solution for injection without active drug, KAI-9531
Kailera Therapeutics
Obesity
1 trial -
Wegovy 0.25 mg FlexTouch solution for injection in pre-filled pen, Wegovy 0.5 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1.7 mg FlexTouch solution for injection in pre-filled pen, Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen, KAI-9531, Wegovy 1 mg FlexTouch solution for injection in pre-filled pen, KAI-9531, KAI-9531
Kailera Therapeutics
Obesity
1 trial
Frequently asked questions
How many pipeline programs does Kailera Therapeutics have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs